SynthesisDiabetes, obesity & metabolism2026
Early versus late initiation of long-acting insulin in paediatric and adult diabetic ketoacidosis: A systematic review and meta-analysis of randomised control trials.
Synthesis in Diabetes, obesity & metabolism, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
aimsDiabetic ketoacidosis (DKA) is a serious complication of diabetes, requiring intravenous (IV) insulin until resolution and subsequent transition to subcutaneous insulin. Currently, clinical guidelines vary regarding the timing of long-acting subcutaneous insulin initiation, with some advocating early administration during IV insulin infusion, while others recommend delaying until DKA resolution. We aimed to evaluate the efficacy and safety of concurrent versus sequential initiation of long-acting subcutaneous insulin in paediatric and adult patients with DKA already receiving regular insulin. MATERIALS AND
methodsA systematic search of five databases (inception to January 2026) identified eligible studies. Early initiation was defined as administration of long-acting insulin before resolution of DKA, while late initiation occurred after resolution of DKA. Primary outcomes included time to DKA resolution, total IV insulin and fluid requirements, and risks of hypoglycaemia, hypokalaemia, and rebound hyperglycaemia. Pooled effect sizes were calculated using random-effects models.
resultsNine randomised control trials encompassing 652 patients were included. Early long-acting insulin was associated with a shorter time to DKA resolution (SMD: -0.61; 95% CI: -0.83 to -0.38) and was associated with lower total insulin and fluid requirements. Available evidence was insufficient to rule out an increased risk of hypoglycaemia (RR: 0.81; 95% CI: 0.52-1.27) or hypokalaemia (RR: 1.21; 95% CI: 0.90-1.63).
conclusionsEarly initiation of long-acting insulin during IV insulin infusion in DKA likely shortens time to resolution based on moderate certainty evidence and may reduce total insulin and fluid requirements. Evidence for rebound hyperglycaemia and recurrent DKA outcomes remains limited and imprecise.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.